<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04031626002495</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0085</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T19:45:52.587Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001733</udiDi>
    <basicUdiDi>4031626101365NL</basicUdiDi>
    <tradeName>hysan Pflegespray</tradeName>
    <deviceName>Moistening solution for nasal use based on sodium hyaluronate and dexpanthenol</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0078</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T14:00:02.060Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001719</udiDi>
    <basicUdiDi>4031626101420N3</basicUdiDi>
    <tradeName>hysan Hyaluronspray</tradeName>
    <deviceName>Moistening solution for nasal use based on sodium hyaluronate</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0077</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T14:00:01.260Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001542</udiDi>
    <basicUdiDi>4031626103064NH</basicUdiDi>
    <tradeName>hysan Hypertonic Nasal Spray</tradeName>
    <deviceName>Hypertonic salt solution for nasal use</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.1821</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:59:57.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001177</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName>Lubricating eye ointment with vitamin A</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2536</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:59:56.563Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001153</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName>Lubricating eye drops with 0.03% sodium hyaluronate</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2548</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:59:41.200Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001115</udiDi>
    <basicUdiDi>4031626551134RA</basicUdiDi>
    <tradeName>EvoTears</tradeName>
    <deviceName>Perfluorohexyloctane ophthalmic solution</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2550</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:59:40.410Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626000866</udiDi>
    <basicUdiDi>40316260651657052T</basicUdiDi>
    <tradeName>POSIFORLID ocní maska</tradeName>
    <deviceName>POSIFORLID Augenmaske</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M9001</emdnCode>
    <emdnDescription>CRYOTHERAPY AND THERMOTHERAPY DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0016</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:59:39.590Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001917</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2053</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-17T19:49:39.222Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002488</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0080</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T21:06:51.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002297</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO-FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.1368</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T21:06:50.299Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002600</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.1139</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T21:05:45.083Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002549</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA-POS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:39.036Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002280</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:38.187Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002150</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:37.329Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002051</udiDi>
    <basicUdiDi>4031626101365NL</basicUdiDi>
    <tradeName>Återfuktande Nässpray Apofri</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:36.469Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002044</udiDi>
    <basicUdiDi>4031626101365NL</basicUdiDi>
    <tradeName>Återfuktande Nässpray ABECE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:35.634Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002006</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:34.801Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001962</udiDi>
    <basicUdiDi>4031626101365NL</basicUdiDi>
    <tradeName>hysan Care Nasal Spray</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:33.926Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001894</udiDi>
    <basicUdiDi>4031626101365NL</basicUdiDi>
    <tradeName>hysan CARE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030103</emdnCode>
    <emdnDescription>NASAL IRRIGATION SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-13T09:23:33.072Z</lastUpdated>
  </row>
</eudamedExport>